Add office photos
Employer?
Claim Account for FREE
Sanofi
4.1
based on 1.3k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Sanofi
Company Summary
Sanofi provides potentially life-changing treatments and the protection of life-saving vaccines to millions of people
Overall Rating
4.1/5
based on 1.3k reviews
5% above
industry average
Highly rated for
Work-life balance, Company culture, Skill development
Critically rated for
Promotions
Work Policy
Hybrid
70% employees reported
Monday to Friday
44% employees reported
Flexible timing
75% employees reported
Within city
37% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
104 employees reported
Health insurance
101 employees reported
Office cab/shuttle
74 employees reported
Cafeteria
50 employees reported
View all benefits
About Sanofi
Founded in2004 (21 yrs old)
India Employee Count1k-5k
Global Employee Count1 Lakh+
HeadquartersParis, France
Office Locations
--
Websitesanofi.in
Primary Industry
Other Industries
Are you managing Sanofi's employer brand? To edit company information,
claim this page for free
View in video summary
Every journey has its ups and downs. But during trying times, a right partner can make all the difference. In India, Sanofi has been a partner for over 60 years. Each one of our 5000+ employees identifies with people’s health journey and hence, is dedicated towards making a difference and supporting them during their health challenges. We pride ourselves in helping prevent diseases, achieve wellness and treat a vast range of illnesses – some common and others rare.
Report error
Managing your company's employer brand?
Claim this Company Page for FREE
ABECA - AmbitionBox Employee Choice Awards
Best of the best, rated by employees
Sanofi won India’s Largest Employee Choice Awards in Mid-Sized Companies Category.
#3 Top Rated Mid-Sized Company
#4 Top Rated Company for Women
#1 Top Rated Pharma Company
Share
Sanofi Ratings
based on 1.3k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
775
4
321
3
104
2
47
1
51
Category Ratings
4.2
Work-life balance
4.1
Company culture
3.9
Skill development
3.9
Work satisfaction
3.8
Job security
3.8
Salary
3.3
Promotions
Sanofi is rated 4.1 out of 5 stars on AmbitionBox, based on 1.3k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Sanofi
based on 1.2k reviews
4.1
Rated by 249 Women
Rated 4.2 for Work-life balance and 4.1 for Company culture
4.1
Rated by 992 Men
Rated 4.2 for Work-life balance and 4.1 for Company culture
Work Policy at Sanofi
based on 160 reviews in last 6 months
Hybrid
70%
Work from office
29%
Permanent work from home
1%
Sanofi Reviews
Top mentions in Sanofi Reviews
+ 5 more
Compare Sanofi with Similar Companies
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 1.3k reviews  | 4.1/5 based on 3.3k reviews | 3.8/5 based on 3.7k reviews | 4.1/5 based on 3.4k reviews |
Highly Rated for | Work-life balance Company culture Skill development | Skill development Work-life balance Salary | Job security | Salary Job security Work-life balance |
Critically Rated for | Promotions | Promotions | Promotions |  No critically rated category |
Primary Work Policy | Hybrid 70% employees reported | Work from office 55% employees reported | Work from office 89% employees reported | Work from office 76% employees reported |
Rating by Women Employees | 4.1 Good rated by 249 women | 4.0 Good rated by 421 women | 4.0 Good rated by 392 women | 4.0 Good rated by 343 women |
Rating by Men Employees | 4.1 Good rated by 992 men | 4.1 Good rated by 2.7k men | 3.8 Good rated by 3.1k men | 4.2 Good rated by 2.9k men |
Job security | 3.8 Good | 3.8 Good | 4.0 Good | 4.1 Good |
View more
Sanofi Salaries
Sanofi salaries have received with an average score of 3.8 out of 5 by 1.3k employees.
Scientific Sales Executive
(208 salaries)
Unlock
₹4.1 L/yr - ₹8.5 L/yr
Territory Manager
(196 salaries)
Unlock
₹5.1 L/yr - ₹11.5 L/yr
Senior Analyst
(108 salaries)
Unlock
₹15.7 L/yr - ₹27 L/yr
Analyst
(74 salaries)
Unlock
₹10.9 L/yr - ₹16 L/yr
Senior Scientific Sales Executive
(72 salaries)
Unlock
₹4.2 L/yr - ₹9 L/yr
Project Specialist
(63 salaries)
Unlock
₹7.6 L/yr - ₹13.6 L/yr
Deputy Manager
(60 salaries)
Unlock
₹10.6 L/yr - ₹18 L/yr
Diabetes Educator
(56 salaries)
Unlock
₹1.7 L/yr - ₹4.5 L/yr
Officer
(54 salaries)
Unlock
₹2.4 L/yr - ₹5.7 L/yr
Senior Scientific Writer
(52 salaries)
Unlock
₹12.6 L/yr - ₹22.5 L/yr
Sanofi Interview Questions
A Shift Engineer was asked Q. Are all systems working properly?
A Quality System Specialist was asked Q. Explain the process of proposing risk mitigation and risk acceptance a...read more
A Quality Assurance Specialist was asked 7mo agoQ. What is your expected CTC?
An Intern was asked Q. Why are you interested in marketing and strategy?
An Area Business Manager was asked Q. How will you handle bias?
Sanofi Jobs
Popular Designations Sanofi Hires for
Popular Skills Sanofi Hires for
Current Openings
Sanofi News
View all
Novisto helps companies track their sustainability efforts. Check out the 17-slide deck it used to raise a $27 million Series C.
- Novisto, a company helping companies track their ESG efforts, has raised $27 million in Series C funding to expand its corporate ESG tracking platform.
- The platform automates sustainability data management and works with companies like Meta and Sanofi.
- Novisto's software platform helps clients monitor and measure their sustainability impacts, acting as a system of record for broader sustainability-related data for corporates.
- The Series C funding was led by Inovia Capital, bringing Novisto's total funding to $55 million. The company plans to grow its team in Europe with the fresh funding.
Insider | 20 May, 2025
Why did IGM Biosciences close its labs & cut 80% of workforce?
- IGM Biosciences has closed a significant number of labs and offices and cut 80% of its workforce due to Sanofi ending their partnership.
- With the loss of a major partner, IGM is looking to reduce costs and save cash, leading to organizational reorganization.
- The biotech firm had around 150 full-time employees in 2024, reduced to only about seven after the recent job cuts.
- Sanofi and IGM's partnership involved co-development of IGM antibody agonists, but the agreement was altered in April 2024, limiting the number of targets.
HRKatha | 12 May, 2025
Dr Reddy's To Introduce Sanofi's Novel RSV Drug Beyfortus In India
- Dr Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce the novel drug Beyfortus in India.
- Beyfortus is a prefilled injection used for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants.
- Dr Reddy's will have exclusive rights from Sanofi to promote and distribute Beyfortus in India.
- Beyfortus has been approved for use in several countries and is expected to be launched in India in the second quarter of the current fiscal year.
Bloomberg Quint | 28 Apr, 2025
DRL to distribute Sanofi’s Beyfortus, used to prevent RSV in infants
- Dr Reddy’s to distribute Sanofi’s Beyfortus, used to prevent RSV in infants
- Dr Reddy’s plans to launch Beyfortus in India in Q2 of the current fiscal year
- Beyfortus contains nirsevimab to prevent RSV lower respiratory tract disease in newborns and infants
- RSV is a contagious virus causing respiratory illness; Beyfortus aims to reduce hospitalizations in infants
HinduBusinessLine | 28 Apr, 2025
Dividends This Week — Muthoot Finance, Sanofi India, Schaeffler India And More
- Several companies including Schaeffler India, Muthoot Finance, and Sanofi India will distribute dividends.
- Muthoot Finance: The company has announced an interim dividend of Rs 24 per share for eligible shareholders.
- Sanofi India: The company has announced a final dividend of Rs 117 per share for the year ended December 31, 2024.
- Schaeffler India: The company has announced a final dividend of Rs 28 per share.
Bloomberg Quint | 21 Apr, 2025
%2011_07_24.jpg?w=1200&auto=format%2Ccompress&ogImage=true)
Corporate Actions This Week — CIE Automotive, Muthoot Finance, Sanofi India, Sterlite Tech
- Shares of CIE Automotive India Ltd., Muthoot Finance Ltd., Ami Organics Ltd., and Sanofi India Ltd. will trade ex/record-date for their corporate actions this week.
- CIE Automotive will record its shareholders' roster on Wednesday for its final dividend of Rs 7 for the financial year 2024–25. Muthoot Finance (interim dividend) and Sanofi India (final dividend of Rs 117) will record their shareholders on Friday.
- The record/ex-date for Ami Organics' stock split of two shares for every one held will be on Friday.
- Sterlite Technologies Ltd. has completed the demerger of its Global Services Business, transitioning to STL Networks Ltd. under the brand name 'Invenia'. The ex/record date for the spinoff is Thursday.
Bloomberg Quint | 20 Apr, 2025
Stock Market Today: All You Need To Know Going Into Trade On April 11
- Stock markets globally were impacted by a steep escalation in the US-China trade war which led to a sharp decline in Asian and US markets.
- Indian equity indices closed in the red as investors reacted to the RBI rate cut and ongoing trade tensions.
- TCS reported Q4 FY25 results with revenue up, but net profit and margin slightly down.
- Stocks to watch include Tata Steel, Infosys, Sanofi India, NBCC, and BHEL, among others, with various developments and announcements.
- Companies like Welspun Corp, Biocon, GAIL, JSW Energy, and Sun Pharma made significant moves and announcements in various sectors.
- Currency market update saw the rupee weakening against the US dollar amid global risk aversion and domestic policy cues.
- Research reports previewing Q4 results for Zomato, Swiggy, Nykaa, cement, specialty chemicals, hotels, metals, and more were discussed.
- Various trading tweaks, block deals, and F&O cues, along with market updates and expert stock insights, were highlighted.
- Overall, the stock market showed volatility influenced by global trade tensions, company earnings, and market developments.
- Investors need to remain cautious and informed about market movements and company-specific events for strategic decision-making.
Bloomberg Quint | 11 Apr, 2025
Where are the GEM students going once they graduate?
- GEM students are highly sought-after by the pharmaceutical industry, particularly by Sanofi. Many GEM alumni can be found at Sanofi due to the proximity between Grenoble and Lyon and the relevant Masters programs taught at GEM.
- Deloitte, specifically in the areas of Audit, Strategy, and Risk Advisory, has a high representation of GEM students. GEM's Masters programs in Finance and related fields align well with Deloitte's recruitment needs.
- EY is in direct competition with Deloitte to employ GEM students. With a focus on the financial and consulting sectors, EY attracts many GEM graduates, particularly from the highly-ranked MSc Finance program at GEM.
- L'Oréal, one of the leading companies in the CAC 40, recruits a significant number of GEM students for various positions, including marketing, digital, HR, and sales. L'Oréal offers employment opportunities to interns and trainees, with a significant portion staying on as full-time employees.
Medium | 1 Apr, 2025
Xi Jinping Meets Global Business Leaders As China Seeks To Woo Investors
- Chinese President Xi Jinping met with a group of global business leaders in Beijing to boost investor sentiment amid rising tariffs and uncertainty for the economy and international trade.
- The meeting took place at the Great Hall of the People and included representatives from international industrial and business firms, such as FedEx Corp, Standard Chartered PLC, Sanofi SA, AstraZeneca PLC, and ThyssenKrupp AG.
- Xi expressed that the Chinese government will study and consider the views shared by the business representatives, while encouraging them to continue their lines of communication with China.
- The meeting emphasizes China's efforts to position itself as open for business and a supporter of private enterprise, countering protectionist policies and fostering economic growth.
Bloomberg Quint | 28 Mar, 2025
ACMG Foundation for Genetic and Genomic Medicine to Unveil Four Next-Generation Fellowship Awards at 2025 Annual Clinical Genetics Meeting
- The ACMG Foundation for Genetic and Genomic Medicine annually awards the Next Generation Fellowship to early career professionals in medical genetics and genomics.
- The fellowship covers specialties such as Clinical Genetics, Clinical Biochemical Genetics, Laboratory Genetics and Genomics, Medical Biochemical Genetics, and Ophthalmic Genetics.
- Corporate sponsors like Bionano, Pfizer, Sanofi, Spark Therapeutics, and Takeda support the development of future leaders in genetic and genomic medicine.
- The 2025 recipients, including Rafael Garrett da Costa, Atlas Sardoo, Emily S. Levine, and Daniel R. Brooks, showcase dedication to advancing genomics.
- Dr. Garrett da Costa specializes in mass spectrometry and metabolomics, focusing on rare metabolic disorders and diagnostic methodologies.
- Dr. Sardoo's work at NIH links viral infections and liver cancer, uniting bioinformatics with clinical practices.
- Dr. Levine, specializing in ophthalmic genetics, aims to enhance care for patients with genetic eye conditions.
- Dr. Brooks, advocating for genetic healthcare accessibility, highlights issues like prenatal diagnostics and rare genetic conditions.
- The ACMG Foundation supports burgeoning clinician-scientists to transform genomic insights into healthcare advancements.
- The fellowship recipients exemplify a commitment to inclusivity, equity, and innovation in medical genetics and genomics.
Bioengineer | 19 Mar, 2025
Powered by
Sanofi Subsidiaries
Shantha Biotechnics
4.7
• 126 reviews
Sanofi Pasteur
3.7
• 76 reviews
Aventis Pharma
4.7
• 9 reviews
Liva
4.7
• 2 reviews
Genzyme
5.0
• 1 review
Report error
Compare Sanofi with
Micro Labs
3.6
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
3.9
Novartis
4.1
Biological E
4.2
USV
4.0
Granules India Limited
3.8
Teva Pharmaceuticals
3.9
Piramal Pharma
4.0
Novo Nordisk
4.0
Eli Lilly and Company
3.7
Otsuka Pharmaceutical India Private Limited
4.1
Par Pharmaceutical Companies
4.3
Novartis Healthcare
4.1
Apex Laboratories
3.9
Agilent Technologies
4.1
Merck
4.2
Apcer Life Sciences
3.6
Pfizer Products India
3.9
Boehringer-Ingelheim
4.0
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Sanofi
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.3k reviews
Micro Labs
Clinical Research, Pharma
3.6
• 2.4k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 2k reviews
Pfizer
Healthcare / Pharma, Manufacturing, Pharma
3.9
• 1.9k reviews
Novartis
Healthcare, Pharma
4.1
• 1.8k reviews
Biological E
Pharma
4.2
• 1.7k reviews
USV
Manufacturing, Pharma
4.0
• 1.5k reviews
Granules India Limited
Manufacturing, Pharma
3.8
• 1.4k reviews
Teva Pharmaceuticals
Healthcare / Pharma, Clinical Research, Pharma
3.9
• 1.4k reviews
Piramal Pharma
Biotech & Life sciences, Pharma
4.0
• 1.2k reviews
Sanofi FAQs
When was Sanofi founded?
Sanofi was founded in 2004. The company has been operating for 21 years primarily in the Pharma sector.
Where is the Sanofi headquarters located?
Sanofi is headquartered in Paris.
How many employees does Sanofi have in India?
Sanofi currently has more than 2,100+ employees in India. Sales & Business Development department appears to have the highest employee count in Sanofi based on the number of reviews submitted on AmbitionBox.
Does Sanofi have good work-life balance?
Sanofi has a work-life balance rating of 4.2 out of 5 based on 1,200+ employee reviews on AmbitionBox. 84% employees rated Sanofi 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read Sanofi work-life balance reviews for more details.
Is Sanofi good for career growth?
Career growth at Sanofi is rated as moderate, with a promotions and appraisal rating of 3.3. 16% employees rated Sanofi 3 or below, while 84% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Sanofi promotions / appraisals reviews for more detailed insights.
What are the pros and cons of working in Sanofi?
Working at Sanofi comes with several advantages and disadvantages. It is highly rated for work life balance, company culture and skill development. However, it is poorly rated for promotions / appraisal, based on 1,200+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
